MetLife, Inc.
MET · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $70 | $68 | $68 | $63 |
| % Growth | 3.3% | -0.4% | 7.3% | – |
| Cost of Goods Sold | $51 | $50 | $49 | $47 |
| Gross Profit | $19 | $17 | $19 | $17 |
| % Margin | 27.2% | 25.5% | 27.9% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6 | $6 | $6 | $6 |
| SG&A Expenses | $6 | $6 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7 | $9 | $7 | $3 |
| Operating Expenses | $13 | $15 | $13 | $8 |
| Operating Income | $6 | $2 | $6 | $9 |
| % Margin | 8% | 3.2% | 9.4% | 13.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $6 | $2 | $6 | $9 |
| Tax Expense | $1 | $1 | $1 | $2 |
| Net Income | $4 | $2 | $5 | $7 |
| % Margin | 6.3% | 2.3% | 7.8% | 10.8% |
| EPS | 5.98 | 1.82 | 6.35 | 7.7 |
| % Growth | 228.6% | -71.3% | -17.5% | – |
| EPS Diluted | 5.94 | 1.81 | 6.3 | 7.65 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $7 | $4 | $8 | $10 |
| % Margin | 10.5% | 5.8% | 11.7% | 16% |